- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01842087
The Effects of Fiber Fortified Foods to the Diets of Chronic Kidney Disease Patients
March 17, 2020 updated by: University of Florida
An Investigation Into Pulse Fiber Fermentation and Nitrogen Excretion in Patients With Chronic Renal Failure
A single blind, six week dietary intervention will be conducted in order to evaluate the impact of fiber fortified foods on blood urea nitrogen, kidney function and quality of life in patients presenting with a moderate to severe decline in kidney function.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Chronic Kidney Disease (CKD) patients may consume lower than recommended amounts of dietary fiber due to typical dietary habits, dietary restrictions, and uremic symptoms.
A progressive decline in kidney function causes an accumulation of uremic molecules that contribute to further progression of the disease and reduced quality of life.
In an effort to evaluate the impact of added fiber on blood urea nitrogen, kidney function and quality of life in patients presenting with a moderate to severe decline in kidney function (eGFR ≤ 50 mL/min/1.73
m2), a single blind, six week dietary intervention, clinical trial will be conducted.
Study Type
Interventional
Enrollment (Actual)
15
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Florida
-
Gainesville, Florida, United States, 32611
- University of Florida
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
Participants must:
- Be 18 years of age or older
- Have eGFR (estimated glomerular filtration rate) of less than 50 mL/min/1.73 m2 (stage 3,4 and 5 but who are not on dialysis)
Exclusion Criteria:
Participants must not:
- Have been diagnosed with acute kidney injury (AKI)
- Have been diagnosed with glumerulonephritis (GN)
- Have been on immunosuppressant/steroid medications
- Be taking a probiotic supplement and refuse to discontinue it
- Be scheduled for dialysis within 3 months of study initiation
- Have a history of liver disease
- Be on dialysis
- Have undergone renal transplantation
- Be breastfeeding
- Have active gastrointestinal bleeding
- Have a change in medications over the past 4 weeks
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: BASIC_SCIENCE
- Allocation: NON_RANDOMIZED
- Interventional Model: SINGLE_GROUP
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
PLACEBO_COMPARATOR: Control Foods
For a period of 2 weeks, participants will consume control foods in addition to their usual diets.
|
For a period of 2 weeks, participants will consume control foods in addition to their usual diets.
Other Names:
|
EXPERIMENTAL: Fiber Fortified Foods
For a period of 4 weeks, participants will consume food fortified with fiber in addition to their usual diets.
|
For a period of 4 weeks, participants will consume food fortified with fiber in addition to their usual diets.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Impact of added fiber on blood urea nitrogen (BUN)
Time Frame: up to 42 days of the study
|
Blood samples (10 mL) will be taken on day 1, 14, 28, and 42.
BUN will be assayed using the Urea Nitrogen Concentrated Reagent method.
|
up to 42 days of the study
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Impact of foods with added fiber on estimated Glomerular Filtration Rate (eGFR)
Time Frame: Days 1, 14, 28 and 42 of the study
|
eGFR will be calculated using the Modification of Diet in Renal Disease formula on days 1, 14, 28 and 42 of the study.
|
Days 1, 14, 28 and 42 of the study
|
Impact of foods with added fiber on Serum Creatinine
Time Frame: Days 1, 14, 28 and 42 of the study
|
Serum creatinine will be assayed using the ADVIA Chemistry CRE_2c method.
|
Days 1, 14, 28 and 42 of the study
|
Impact of foods with added fiber on bowel movement frequency
Time Frame: Daily
|
Participants will complete daily diaries to evaluate bowel movement frequency.
|
Daily
|
Impact of foods with added fiber on Kidney Disease Quality of Life (KDQOL-36) questionnaire
Time Frame: Days 1, 14, 28 and 42
|
Participants will complete the Kidney Disease Quality of Life (KDQOL-36) questionnaire for 4 specific days during the study.
|
Days 1, 14, 28 and 42
|
Impact of foods with added fiber on Simplified Nutritional Appetite Questionnaire (SNAQ)
Time Frame: Days 1, 14, 28 and 42 of the study
|
Days 1, 14, 28 and 42 of the study
|
|
Impact of foods with added fiber on Epworth Sleepiness Scale (ESS)
Time Frame: Days 1, 14, 28 and 42 of the study
|
Days 1, 14, 28 and 42 of the study
|
|
Impact of foods with added fiber on Gastrointestinal Symptom Rating Scale (GSRS)
Time Frame: Days 1, 14, 28 and 42 of the study
|
Days 1, 14, 28 and 42 of the study
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
April 1, 2010
Primary Completion (ACTUAL)
November 1, 2010
Study Completion (ACTUAL)
November 1, 2010
Study Registration Dates
First Submitted
April 18, 2013
First Submitted That Met QC Criteria
April 26, 2013
First Posted (ESTIMATE)
April 29, 2013
Study Record Updates
Last Update Posted (ACTUAL)
March 18, 2020
Last Update Submitted That Met QC Criteria
March 17, 2020
Last Verified
March 1, 2020
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 16-2010
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Chronic Kidney Disease
-
3-C Institute for Social DevelopmentUniversity of North Carolina, Chapel HillCompletedChronic Kidney Diseases | Chronic Kidney Disease Stage 5 | Chronic Kidney Disease stage4 | Pediatric Kidney Disease | Chronic Kidney Disease stage3 | Chronic Kidney Disease Stage V | Chronic Kidney Disease, Stage IV (Severe) | Chronic Kidney Disease Stage 2 | Chronic Kidney Disease, Stage IUnited States
-
Universiti Putra MalaysiaRecruitingChronic Kidney Diseases | Chronic Kidney Disease Stage 5 | Chronic Kidney Disease stage4 | Chronic Kidney Disease stage3 | Chronic Kidney Disease Requiring Chronic DialysisMalaysia
-
National Taiwan University HospitalCompletedChronic Kidney Disease stage4 | Chronic Kidney Disease stage3 | Chronic Kidney Disease Stage 2 | Chronic Kidney Disease Stage 1Taiwan
-
Centre Hospitalier le MansLe Mans UniversiteWithdrawnFatigue | Chronic Kidney Disease Stage 5 | Chronic Kidney Disease stage3 | Chronic Kidney Failure | Chronic Kidney Disease, Stage 4 (Severe)
-
Centre Hospitalier le MansLe Mans UniversiteRecruitingFatigue | Chronic Kidney Disease Stage 5 | Chronic Kidney Disease stage4 | Chronic Kidney Disease Stage 3BFrance
-
American Academy of Family PhysiciansUniversity of Colorado, Denver; National Institute of Diabetes and Digestive... and other collaboratorsCompletedChronic Kidney Disease | Chronic Renal Insufficiency | Chronic Kidney Insufficiency | Chronic Renal Diseases | Kidney Insufficiency, ChronicUnited States
-
Lund UniversityBaxter Healthcare Corporation; Universidad de CórdobaCompletedEnd Stage Kidney Disease | Chronic Kidney Disease Requiring Chronic DialysisArgentina
-
Centre Hospitalier Saint Joseph Saint Luc de LyonNot yet recruitingKidney Failure, Chronic | Diet Habit | Chronic Kidney Disease stage3 | Chronic Kidney Disease Stage 3B | Chronic Kidney Disease, Stage 3 (Moderate) | Chronic Kidney Disease Stage 3A (Disorder)France
-
A.C. AbrahamsCompletedEnd Stage Renal Disease | Chronic Kidney Disease | End Stage Kidney Disease | Chronic Kidney FailureNetherlands
-
Far Eastern Memorial HospitalActive, not recruitingMetabolic Syndrome | Chronic Disease | Chronic Kidney Disease Stage 5 | Chronic Kidney Disease Stage 3 | Chronic Kidney Disease Stage 4 | Chronic Kidney Disease Stage 2 | Chronic Kidney Disease Stage 1Taiwan
Clinical Trials on Control Food
-
CargillCompleted
-
University of ConnecticutTerminated
-
Mondelēz International, Inc.TyraTech TechnologyTerminated
-
Babes-Bolyai UniversityCompleted
-
Duke UniversityUnited States NavyEnrolling by invitationOxygen ToxicityUnited States
-
Helen Keller InternationalMount Saint Vincent University; International Development Research Centre,...Active, not recruitingHealth Behavior | Adolescent Behavior | Marriage AgeBangladesh
-
ICAN Nutrition Education and ResearchAlmond Board of CaliforniaCompletedAdult Young and HealthyKorea, Republic of
-
Na LiuNot yet recruiting
-
Endocrinology and Clinical Nutrition Research Center...Completed
-
Instituto de Investigación Hospital Universitario...Spanish Ministry of industry, tourism and tradeCompletedLow Risk for Cardiovascular DiseaseSpain